Effect of unani medicine in Cervicitis

Effect of Hamul of Marham-e-dakhilyun and Roghan-e-sausan in Cervicitis -An open observational clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023516

Enrollment

Registered

2020-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Marham-e-dakhilyun and Roghan-e-sausan: 10gms marham will be given for Hamul daily at bed time for 21 days after menses. Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1-Married women b/w the age group 18-45 years. 2-Cervicitis diagnosis through p/s examination (Hypertrophy, congestion, redness and Nabothian cyst on cervix). 3-Complaints of vaginal discharge low back ache and low abdominal pain. •Inflammatory changes in Pap smear.

Exclusion criteria

Exclusion criteria: 1-Patients with Pelvic inflammatory disease, Malignancy, benign lesions. 2-Systemic diseases (Hypertension, Thyroid dysfunction ,Diabetes mellitus), Sexually transmitted infections, Intra-uterine contraceptive devices, Oral contraceptives. 3-Pregnancy and lactation.

Design outcomes

Primary

Measure	Time frame
Change in subjective parameters.Timepoint: Duration of therapy is 21 days after menses and follow up weekly.	—

Secondary

Measure	Time frame
Change in objective parameters.Timepoint: Duration of therapy is 21 days after menses and follow up weekly.	—

Countries

India

Contacts

Public ContactHuma

National Institute of Unani Medicine

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026